NCT00318773View on ClinicalTrials.gov

Short-Term Versus Long-Term Treatment for Severe Premenstrual Syndrome (PMS)

PHASE4CompletedINTERVENTIONAL
Enrollment

174

Participants

Timeline

Start Date

February 28, 2002

Primary Completion Date

December 31, 2007

Study Completion Date

February 29, 2008

Conditions
Premenstrual Syndrome
Interventions
DRUG

sertraline

50 - 100 mg daily for 2 weeks before each menses for 4 months or 12 months and then switched to placebo.

Trial Locations (1)

19104

Department of Obstetrics/Gynecology, University of Pennsylvania, School of Medicine, Philadelphia

All Listed Sponsors
lead

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

NIH

NCT00318773 - Short-Term Versus Long-Term Treatment for Severe Premenstrual Syndrome (PMS) | Biotech Hunter | Biotech Hunter